Geron
#6355
Rank
$745.19M
Marketcap
United States
Country
Ms. Olivia Kyusuk Bloom (Exec. VP of Fin., CFO & Treasurer)
Dr. John A. Scarlett M.D. (Chairman, Pres & CEO)
Dr. Andrew J. Grethlein (Exec. VP & COO)
Summary
History
Geron Corporation was founded in 1990. In the early years, the company focused on the development of small-molecule pharmaceuticals, and in 2009, Geron transitioned to a full-time focus on the development of therapeutics for oncology and stem cell-based regenerative medicine applications.
Mission
Vision
Key Team
Ms. Melissa A. Kelly Behrs (Exec. VP of Bus. Operations & Chief Alliance Officer)
Ms. Aron Feingold (VP of Investor Relations & Corp. Communications)
Mr. Stephen N. Rosenfield J.D. (Exec. VP, Chief Legal Officer & Corp. Sec.)
Mr. Anil Kapur (Exec. VP of Corp. Strategy & Chief Commercial Officer)
Ms. Shannon Odam (VP of HR)
Mr. Edward E. Koval (Exec. VP & Chief Bus. Officer)
Dr. Faye Feller M.D. (Exec. VP & Chief Medical Officer)
Recognition and Awards
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Ms. Olivia Kyusuk Bloom (Exec. VP of Fin., CFO & Treasurer)
Dr. John A. Scarlett M.D. (Chairman, Pres & CEO)
Dr. Andrew J. Grethlein (Exec. VP & COO)